midazolam has been researched along with Hypercholesterolemia in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pfefferkorn, JA | 1 |
| Litchfield, J | 1 |
| Hutchings, R | 1 |
| Cheng, XM | 1 |
| Larsen, SD | 1 |
| Auerbach, B | 1 |
| Bush, MR | 1 |
| Lee, C | 1 |
| Erasga, N | 1 |
| Bowles, DM | 1 |
| Boyles, DC | 1 |
| Lu, G | 1 |
| Sekerke, C | 1 |
| Askew, V | 1 |
| Hanselman, JC | 1 |
| Dillon, L | 1 |
| Lin, Z | 1 |
| Robertson, A | 1 |
| Olsen, K | 1 |
| Boustany, C | 1 |
| Atkinson, K | 1 |
| Goosen, TC | 1 |
| Sahasrabudhe, V | 1 |
| Chupka, J | 1 |
| Duignan, DB | 1 |
| Feng, B | 1 |
| Scialis, R | 1 |
| Kimoto, E | 1 |
| Bi, YA | 1 |
| Lai, Y | 1 |
| El-Kattan, A | 1 |
| Bakker-Arkema, R | 1 |
| Barclay, P | 1 |
| Kindt, E | 1 |
| Le, V | 1 |
| Mandema, JW | 1 |
| Milad, M | 1 |
| Tait, BD | 1 |
| Kennedy, R | 1 |
| Trivedi, BK | 1 |
| Kowala, M | 1 |
1 other study available for midazolam and Hypercholesterolemia
| Article | Year |
|---|---|
Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: a bench-to-bedside case study on tissue selective drug distribution.
Topics: Animals; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Hepatocytes; Hepta | 2011 |